251 related articles for article (PubMed ID: 16194548)
1. Stochastic modeling of drug resistance in cancer.
Komarova N
J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548
[TBL] [Abstract][Full Text] [Related]
2. Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer.
Komarova NL; Wodarz D
Theor Popul Biol; 2007 Dec; 72(4):523-38. PubMed ID: 17915274
[TBL] [Abstract][Full Text] [Related]
3. Emergence and prevention of resistance against small molecule inhibitors.
Wodarz D; Komarova NL
Semin Cancer Biol; 2005 Dec; 15(6):506-14. PubMed ID: 16154360
[TBL] [Abstract][Full Text] [Related]
4. Combination therapies against chronic myeloid leukemia: short-term versus long-term strategies.
Komarova NL; Wodarz D
Cancer Res; 2009 Jun; 69(11):4904-10. PubMed ID: 19458080
[TBL] [Abstract][Full Text] [Related]
5. Modeling multi-drug chemotherapy: tailoring treatment to individuals.
Gardner SN
J Theor Biol; 2002 Jan; 214(2):181-207. PubMed ID: 11812172
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of multidrug resistance of ovarian cancer].
Miedzińska-Maciejewska M; Wcisło G
Przegl Lek; 2002; 59(10):854-8. PubMed ID: 12632928
[TBL] [Abstract][Full Text] [Related]
7. Impact of dose-intense chemotherapy on the development of permanent drug resistance.
Coldman AJ; Goldie JH
Semin Oncol; 1987 Dec; 14(4 Suppl 4):29-33. PubMed ID: 3686044
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of cyclic treatments of chronic myeloid leukemia.
Komarova NL
Math Biosci Eng; 2011 Apr; 8(2):289-306. PubMed ID: 21631131
[TBL] [Abstract][Full Text] [Related]
9. Modelling chemotherapy resistance in palliation and failed cure.
Monro HC; Gaffney EA
J Theor Biol; 2009 Mar; 257(2):292-302. PubMed ID: 19135065
[TBL] [Abstract][Full Text] [Related]
10. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
Murray JM
IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemotherapy.
Secchi GC
Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
[TBL] [Abstract][Full Text] [Related]
13. Application of theoretical models to chemotherapy protocol design.
Goldie JH; Coldman AJ
Cancer Treat Rep; 1986 Jan; 70(1):127-31. PubMed ID: 3510731
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug resistance in patients with metastatic breast cancer.
Wong ST; Goodin S
Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
[TBL] [Abstract][Full Text] [Related]
15. The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics.
Gaffney EA
Bull Math Biol; 2005 May; 67(3):563-611. PubMed ID: 15820743
[TBL] [Abstract][Full Text] [Related]
16. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
Hu X; Xuan Y
Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
[TBL] [Abstract][Full Text] [Related]
17. Advances in cancer therapeutics: chemotherapy.
DeVita VT
Prog Clin Biol Res; 1983; 132A():47-69. PubMed ID: 6634746
[TBL] [Abstract][Full Text] [Related]
18. Modeling therapy resistance in genetically engineered mouse cancer models.
Rottenberg S; Jonkers J
Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
Coley HM
Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
[TBL] [Abstract][Full Text] [Related]
20. Role of angiogenesis in drug resistance.
Mattern J
Anticancer Res; 2001; 21(6B):4265-70. PubMed ID: 11908680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
